No Data
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy
Ginkgo Bioworks, Carnegie Mellon University Secure $9.4 Mln To Build Devices For Disease Treatment
Ginkgo Bioworks Secures $9.4M Partnership With Carnegie Mellon To Develop Implantable Cell-Based Bioelectronic Devices For Treating Endocrine Disorders Under ARPA-H's REACT Program
Express News | Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under Arpa-H's React Program
Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program